Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25691 | 227 | 46.6 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
989 | 10020 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | C FES | Author keyword | 38 | 89% | 7% | 17 |
2 | FER KINASE | Author keyword | 4 | 67% | 2% | 4 |
3 | FPS FES | Author keyword | 4 | 67% | 2% | 4 |
4 | ENDOTHELIAL CELL BIOL | Address | 4 | 24% | 7% | 15 |
5 | FER | Author keyword | 3 | 19% | 6% | 14 |
6 | C FPS | Author keyword | 1 | 100% | 1% | 2 |
7 | FES TYROSINE KINASE | Author keyword | 1 | 100% | 1% | 2 |
8 | MAST CELL SIGNALING | Author keyword | 1 | 50% | 0% | 1 |
9 | MYELOID SPECIFIC GENE EXPRESSION | Author keyword | 1 | 50% | 0% | 1 |
10 | SDF 1ALPHA | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | C FES | 38 | 89% | 7% | 17 | Search C+FES | Search C+FES |
2 | FER KINASE | 4 | 67% | 2% | 4 | Search FER+KINASE | Search FER+KINASE |
3 | FPS FES | 4 | 67% | 2% | 4 | Search FPS+FES | Search FPS+FES |
4 | FER | 3 | 19% | 6% | 14 | Search FER | Search FER |
5 | C FPS | 1 | 100% | 1% | 2 | Search C+FPS | Search C+FPS |
6 | FES TYROSINE KINASE | 1 | 100% | 1% | 2 | Search FES+TYROSINE+KINASE | Search FES+TYROSINE+KINASE |
7 | MAST CELL SIGNALING | 1 | 50% | 0% | 1 | Search MAST+CELL+SIGNALING | Search MAST+CELL+SIGNALING |
8 | MYELOID SPECIFIC GENE EXPRESSION | 1 | 50% | 0% | 1 | Search MYELOID+SPECIFIC+GENE+EXPRESSION | Search MYELOID+SPECIFIC+GENE+EXPRESSION |
9 | SDF 1ALPHA | 1 | 50% | 0% | 1 | Search SDF+1ALPHA | Search SDF+1ALPHA |
10 | FLT 3 MUTATION | 0 | 33% | 0% | 1 | Search FLT+3+MUTATION | Search FLT+3+MUTATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FPS FES | 50 | 86% | 11% | 25 |
2 | C FES | 29 | 73% | 10% | 22 |
3 | HEMATOPOIETIC HOMEOSTASIS | 15 | 82% | 4% | 9 |
4 | TRANSCRIPT FERT | 14 | 64% | 6% | 14 |
5 | CORTACTIN PHOSPHORYLATION | 10 | 63% | 4% | 10 |
6 | FUJINAMI SARCOMA VIRUS | 10 | 37% | 9% | 21 |
7 | FPS FES PROTOONCOGENE | 9 | 83% | 2% | 5 |
8 | HUMAN C FES | 9 | 83% | 2% | 5 |
9 | V FPS | 8 | 52% | 5% | 11 |
10 | V FES | 8 | 100% | 2% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Closing in on the biological functions of FPS/FES and FER | 2002 | 132 | 117 | 50% |
Role of the Non-Receptor Tyrosine Kinase Fes in Cancer | 2011 | 4 | 89 | 51% |
Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review) | 2007 | 25 | 92 | 26% |
The c-Fes family of protein-tyrosine kinases | 1998 | 45 | 124 | 36% |
Role of c-Fes in normal and neoplastic hematopoiesis | 1996 | 9 | 64 | 48% |
FER as a novel target for cancer therapy | 2007 | 1 | 87 | 30% |
Signal transduction pathways regulating hematopoietic differentiation | 1998 | 32 | 216 | 11% |
ROLE OF C-FES PROTOONCOGENE IN MYELOID DIFFERENTIATION | 1995 | 3 | 111 | 22% |
EGFR and NF-kappa B: partners in cancer | 2015 | 0 | 76 | 4% |
NOVEL RECEPTOR PROTEIN-TYROSINE KINASES | 1990 | 3 | 10 | 10% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ENDOTHELIAL CELL BIOL | 4 | 24% | 6.6% | 15 |
2 | QUEENS UNIV CANC | 1 | 29% | 0.9% | 2 |
3 | HEMATOPOIESE MOL FONCTIONNELLE | 0 | 33% | 0.4% | 1 |
4 | SIGNALISAT | 0 | 33% | 0.4% | 1 |
5 | DISCAFFDFB | 0 | 25% | 0.4% | 1 |
6 | SHENZHEN HOSPSHENZHEN PKU HKUST MED | 0 | 25% | 0.4% | 1 |
7 | UTRECHT PHARMACEUT | 0 | 25% | 0.4% | 1 |
8 | DEV BIOL MOL BIOL | 0 | 20% | 0.4% | 1 |
9 | MED BIOMETRY INFORMAT EPIDEMIOL IMBIE | 0 | 20% | 0.4% | 1 |
10 | HEMOPOIESIS LEUKEMIA | 0 | 17% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000224703 | C FGR//TYROSINE PROTEIN KINASE//CSK |
2 | 0.0000106060 | PU1//SPI 1 PU1//SFPI1 PU1 |
3 | 0.0000099684 | C ABL//BCR ABL//BCR ABL ONCOPROTEIN |
4 | 0.0000094880 | GM CSF RECEPTOR//BLAST COLONIES//COMMON BETA SUBUNIT |
5 | 0.0000076039 | PODOSOMES//INVADOPODIA//CORTACTIN |
6 | 0.0000063399 | DYNAMIN//F BAR DOMAIN//AMPHIPHYSIN |
7 | 0.0000061502 | GRB2//SH2 DOMAIN//SH3 DOMAIN |
8 | 0.0000060916 | COLLAPSIN RESPONSE MEDIATOR PROTEIN//CRMP2//CRMP 2 |
9 | 0.0000060284 | CAPK//CAMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT//PATHOCHEM |
10 | 0.0000047122 | MIG 6//ACK1//RALT |